{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:29:37Z","timestamp":1770884977385,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T00:00:00Z","timestamp":1262649600000},"content-version":"vor","delay-in-days":796,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["beva.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Equine Veterinary Journal"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Reasons for performing study<\/jats:italic>\n                    : In Europe the incidence of botulism in horses has increased in the last decade due to the growing popularity of haylage feeding. Recombinant vaccines are safer and less expensive to produce and are generally better tolerated than toxoids.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objectives<\/jats:italic>\n                    : To investigate whether the recombinant C\u2010terminal half of the heavy chain of the botulinum neurotoxin C (Hc BoNT\/C) in combination with an immunstimulatory adjuvant is an appropriate vaccine candidate for horses by testing its efficacy to induce neutralising antibodies and by comparing its immunogenic properties and adverse reactions to a commercial toxoid vaccine. Formation of oedema and local pain reactions were assessed. ELISA and Western blot assay against Hc BoNT\/C and testing of neutralising antibody induction in a mouse protection assay were used to evaluate the immune response.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    : With the recombinant vaccine, only minor local swelling with full recovery after 5 days was noted after brisket injections. The toxoid vaccine produced local, painful reactions with longer recovery periods of up to 2 weeks. Horses vaccinated with either vaccine induced neutralising antibodies after the second booster vaccination, while seroconversion on ELISA and Western blot to Hc BoNT\/C was apparent after the first recombinant vaccination, and at various time points in the vaccination schedule in horses that received commercial toxoid vaccine.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : The recombinant vaccine showed fewer adverse reactions compared to the only commercially available vaccine but induced similar concentrations of neutralising antibodies. There was no correlation between the serological response to Hc BoNT\/C and the neutralising capacity of serum.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Potential relevance<\/jats:italic>\n                    : Recombinant Hc BoNT\/C is an appropriate vaccine candidate to stimulate production of neutralising antibodies against botulinum neurotoxin C in horses and creates only minor local reactions at the injection site.\n                  <\/jats:p>","DOI":"10.2746\/042516407x236550","type":"journal-article","created":{"date-parts":[[2007,10,28]],"date-time":"2007-10-28T18:09:15Z","timestamp":1193594955000},"page":"516-520","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Alternative vaccination against equine botulism (BoNT\/C)"],"prefix":"10.1111","volume":"39","author":[{"given":"J.","family":"Frey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mazuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schatzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"Anon(1998)Botulism in the United States 1899\u20131996.Handbook for Epidemiologists Clinicians and Laboratory Workers.Centers for Disease Control and Prevention."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.8.1059"},{"key":"e_1_2_1_4_1","volume-title":"Current Protocols in Molecular Biology 5","author":"Ausubel F.M.","year":"1999"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2006.02.013"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.06.012"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(00)01173-1"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/iai.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton M.A.","year":"1995","journal-title":"Infect. Immun."},{"key":"e_1_2_1_9_1","first-page":"71","volume-title":"Clostridium. Proceedings of the Meeting \u2018Food microbiology and sporulation of the genus Clostridium","author":"D\u00fcrre P.","year":"2004"},{"key":"e_1_2_1_10_1","unstructured":"Eberle S.(2007)Vaccination against Clostridium botulinum type C in Horses using Recombinant Peptides of the C'\u2010terminal half of Hc BoNT\/CD and BoNT\/C Toxoid: Active Immunity and Clinical Side Effects.PhD Thesis Bern."},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/iai.55.11.2541-2545.1987","article-title":"Immunization of mice against tetanus with fragments of tetanus toxin synthesized","volume":"55","author":"Fairweather N.F.","year":"1987","journal-title":"Escherichia coli. Infect. Immun."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(17)30053-6"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1024\/0036-7281.148.10.553"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6580"},{"key":"e_1_2_1_15_1","volume-title":"Antibodies. A Laboratory Manual","author":"Harlow E.","year":"1988"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.2746\/042516401776563418"},{"key":"e_1_2_1_17_1","first-page":"165","article-title":"The antibody response of cattle to Clostridium botulinum Types C and D toxoids","volume":"43","author":"Jansen B.C.","year":"1976","journal-title":"Onderstepoort J. vet. Res."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.19.2.298-314.2006"},{"key":"e_1_2_1_19_1","first-page":"65","article-title":"The immunization of bovines against lamsiekte","volume":"9","author":"Mason J.H.","year":"1938","journal-title":"J. S. Afr. vet. Med. Ass."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-85173-5_8"},{"key":"e_1_2_1_21_1","first-page":"425","article-title":"Ent\u00e9rotoxines bact\u00e9riennes: structure, mode d'action et approche vaccinale","volume":"147","author":"Popoff M.R.","year":"1996","journal-title":"Revue M\u00e9d. V\u00e9t."},{"key":"e_1_2_1_22_1","unstructured":"Popoff M.R.(2003)Molecular biology of clostridial neurotoxins. In:Protein toxins of the GenusClostridiumand Vaccination. Proceedings of the Meeting Eds:C.Duchesnes J.Mainil M.PopoffandR.Titball Presses de la Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire de l'Universit\u00e9 de Li\u00e8ge Li\u00e8ge. pp25\u201344."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00171-8"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.2.717"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1128\/jcm.26.11.2351-2356.1988","article-title":"Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme\u2010linked immunosorbent assay","volume":"26","author":"Siegel L.S.","year":"1988","journal-title":"J. clin. Microbiol."},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/jcm.27.8.1906-1908.1989","article-title":"Evaluation of neutralizing antibodies to Type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid","volume":"27","author":"Siegel L.S.","year":"1989","journal-title":"J. clin. Microbiol."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.2746\/042516407X158368"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.06.094"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507596200"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.1988.tb01545.x"}],"container-title":["Equine Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2746%2F042516407X236550","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/pdf\/10.2746\/042516407X236550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:58:02Z","timestamp":1762070282000},"score":1,"resource":{"primary":{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/10.2746\/042516407X236550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.2746\/042516407X236550"],"URL":"https:\/\/doi.org\/10.2746\/042516407x236550","archive":["Portico"],"relation":{},"ISSN":["0425-1644","2042-3306"],"issn-type":[{"value":"0425-1644","type":"print"},{"value":"2042-3306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"2010-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}